Amendment No. 3 to Schedule 13D for Biomea Fusion, Inc.

This Amendment No. 3 to Schedule 13D, filed on October 10, 2025, pertains to the Common Stock of Biomea Fusion, Inc. The filing is made by Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asset Management, LP, and Bihua Chen. The amendment updates the ownership details of the reporting persons, who collectively own between 2.48% and 5.31% of the company's Common Stock. The filing indicates no transactions in the company's securities occurred in the 60 days prior to the filing. The percentages are based on the company's public offering and subsequent filings.